BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 25003906)

  • 1. [Role of pretherapeutic biomarkers in lung cancer with special regards to bronchoscopic procedures].
    Darwiche K; Özkan F; Ting S; Johnen G; Brüning T; Soltermann A; Huber LC; Christoph DC; Freitag L; Franzen D
    Pneumologie; 2014 Nov; 68(11):719-26. PubMed ID: 25003906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines.
    Wang Y; Hu Y; Wang D; Yu K; Wang L; Zou Y; Zhao C; Zhang X; Wang P; Ying K
    Cancer Biomark; 2012; 11(4):129-37. PubMed ID: 23144150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A panel of protein markers for the early detection of lung cancer with bronchial brushing specimens.
    Liu YZ; Jiang YY; Wang BS; Hao JJ; Shang L; Zhang TT; Cao J; Xu X; Zhan QM; Wang MR
    Cancer Cytopathol; 2014 Nov; 122(11):833-41. PubMed ID: 25045014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening and early detection of lung cancer.
    Van't Westeinde SC; van Klaveren RJ
    Cancer J; 2011; 17(1):3-10. PubMed ID: 21263260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological markers in lung cancer: A clinician's perspective.
    Tufman A; Huber RM
    Cancer Biomark; 2010; 6(3-4):123-35. PubMed ID: 20660959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of lung cancer: a bronchoscopist's perspective.
    Griffin JP; Zaman MK; Niell HB; Tolley EA; Cole FH; Weiman DS
    J Bronchology Interv Pulmonol; 2012 Jan; 19(1):12-8. PubMed ID: 23207257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic yield of flexible bronchoscopic procedures in lung cancer patients according to tumour location.
    Liam CK; Pang YK; Poosparajah S
    Singapore Med J; 2007 Jul; 48(7):625-31. PubMed ID: 17609823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study of the volatile organic compounds exhaled by lung cancer cells in vitro for breath diagnosis.
    Chen X; Xu F; Wang Y; Pan Y; Lu D; Wang P; Ying K; Chen E; Zhang W
    Cancer; 2007 Aug; 110(4):835-44. PubMed ID: 17599760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in bronchoscopy--new and upcoming bronchoscopic methods at the dawn of the 21st century.
    Chhajed PN; Lee P; Tamm M
    J Assoc Physicians India; 2004 Dec; 52():970-4. PubMed ID: 15884455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exhaled biomarkers in lung cancer.
    Horváth I; Lázár Z; Gyulai N; Kollai M; Losonczy G
    Eur Respir J; 2009 Jul; 34(1):261-75. PubMed ID: 19567608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation of cell blocks for lung cancer diagnosis and prediction: protocol and experience of a high-volume center.
    Kossakowski CA; Morresi-Hauf A; Schnabel PA; Eberhardt R; Herth FJ; Warth A
    Respiration; 2014; 87(5):432-8. PubMed ID: 24457174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Virtual bronchoscopy and bronchofiberoscopy--a comparison of diagnostic value in assessment of centrally localized lung tumor].
    Radwan-Röhrenschef P; Burakowska B
    Pneumonol Alergol Pol; 2012; 80(2):127-39. PubMed ID: 22370981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of bronchoscopy in lung cancer.
    Arroliga AC; Matthay RA
    Clin Chest Med; 1993 Mar; 14(1):87-98. PubMed ID: 8462250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interobserver agreement and assay reproducibility of folate receptor α expression in lung adenocarcinoma: a prognostic marker and potential therapeutic target.
    Bremer RE; Scoggin TS; Somers EB; O'Shannessy DJ; Tacha DE
    Arch Pathol Lab Med; 2013 Dec; 137(12):1747-52. PubMed ID: 23570254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement factor H is elevated in bronchoalveolar lavage fluid and sputum from patients with lung cancer.
    Pio R; Garcia J; Corrales L; Ajona D; Fleischhacker M; Pajares MJ; Cardenal F; Seijo L; Zulueta JJ; Nadal E; Witt C; Lozano MD; Schmidt B; Montuenga LM
    Cancer Epidemiol Biomarkers Prev; 2010 Oct; 19(10):2665-72. PubMed ID: 20802023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In situ detection of lung cancer volatile fingerprints using bronchoscopic air-sampling.
    Santonico M; Lucantoni G; Pennazza G; Capuano R; Galluccio G; Roscioni C; La Delfa G; Consoli D; Martinelli E; Paolesse R; Di Natale C; D'Amico A
    Lung Cancer; 2012 Jul; 77(1):46-50. PubMed ID: 22264635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic Utility of Bronchial Brush-Tip Washings for the Immunohistochemical Assessment of Peripheral Lung Lesions.
    Bonney A; Beaty A; See K; Irving L; Steinfort D
    Acta Cytol; 2016; 60(1):74-8. PubMed ID: 26918654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of MGB1 as a marker in the differential diagnosis of lung tumors in patients with a history of breast cancer by analysis of publicly available SAGE data.
    Koga T; Horio Y; Mitsudomi T; Takahashi T; Yatabe Y
    J Mol Diagn; 2004 May; 6(2):90-5. PubMed ID: 15096563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative breath analysis of volatile organic compounds of lung cancer patients.
    Song G; Qin T; Liu H; Xu GB; Pan YY; Xiong FX; Gu KS; Sun GP; Chen ZD
    Lung Cancer; 2010 Feb; 67(2):227-31. PubMed ID: 19409642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Update in bronchoscopic techniques].
    Simon M; Simon I
    Pneumologia; 2010; 59(1):53-6. PubMed ID: 20432795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.